D&D Pharmatech Inc. (KOSDAQ: 347850)
South Korea
· Delayed Price · Currency is KRW 47,000
-100 (-0.21%)
Dec 20, 2024, 9:00 AM KST
D&D Pharmatech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -18,717 | 3,934 | -136,067 | -68,224 | -63,406 | -6,359 | Upgrade
|
| Depreciation & Amortization | 5,211 | 4,428 | 13,739 | 11,901 | 11,343 | 7,859 | Upgrade
|
| Loss (Gain) From Sale of Assets | 215.47 | 84.78 | -21,524 | - | - | 35.85 | Upgrade
|
| Asset Writedown & Restructuring Costs | -4,582 | -4,582 | 119,722 | - | 494.42 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -45,993 | Upgrade
|
| Loss (Gain) on Equity Investments | 3,183 | 1,787 | 9,148 | - | - | -14,414 | Upgrade
|
| Stock-Based Compensation | 498.03 | 2,843 | 4,057 | 5,576 | 4,739 | 2,100 | Upgrade
|
| Other Operating Activities | -284.71 | -15,025 | -39,488 | -7,399 | -4,406 | 37,245 | Upgrade
|
| Change in Accounts Receivable | -2,156 | -3,618 | -231.5 | 897.49 | 195.91 | -118.24 | Upgrade
|
| Change in Other Net Operating Assets | 1,081 | 1,030 | -2,439 | 5,304 | 2,460 | -2,379 | Upgrade
|
| Operating Cash Flow | -15,551 | -9,117 | -53,083 | -51,945 | -48,580 | -22,023 | Upgrade
|
| Capital Expenditures | -267.61 | -45.22 | -711.88 | -1,615 | -2,596 | -1,519 | Upgrade
|
| Sale of Property, Plant & Equipment | 141.51 | 323.21 | 240.02 | - | - | 60 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -18,183 | Upgrade
|
| Sale (Purchase) of Intangibles | -20 | - | -7.03 | -603.83 | -511.81 | -8.82 | Upgrade
|
| Investment in Securities | - | - | - | - | - | -5,175 | Upgrade
|
| Other Investing Activities | -463.55 | -9.84 | - | 263.02 | -225.27 | -602.08 | Upgrade
|
| Investing Cash Flow | -609.66 | 268.14 | -478.89 | -1,955 | -3,333 | -25,429 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 31,000 | Upgrade
|
| Long-Term Debt Issued | - | 1,000 | 3,217 | 6,329 | 662.14 | - | Upgrade
|
| Total Debt Issued | - | 1,000 | 3,217 | 6,329 | 662.14 | 31,000 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -31,000 | Upgrade
|
| Long-Term Debt Repaid | - | -1,625 | -1,378 | -774.99 | -556.56 | -320.49 | Upgrade
|
| Total Debt Repaid | -1,738 | -1,625 | -1,378 | -774.99 | -556.56 | -31,320 | Upgrade
|
| Net Debt Issued (Repaid) | -1,738 | -625.25 | 1,839 | 5,554 | 105.58 | -320.49 | Upgrade
|
| Issuance of Common Stock | 37,375 | - | 147 | 3,014 | - | 16,732 | Upgrade
|
| Other Financing Activities | -3.97 | -4.67 | -0 | -0 | - | -0 | Upgrade
|
| Financing Cash Flow | 35,633 | -629.92 | 1,986 | 67,692 | 105.58 | 157,385 | Upgrade
|
| Foreign Exchange Rate Adjustments | -319.54 | -382.5 | 1,123 | 1,554 | -638.45 | -173.41 | Upgrade
|
| Net Cash Flow | 19,152 | -9,862 | -50,454 | 15,346 | -52,446 | 109,759 | Upgrade
|
| Free Cash Flow | -15,819 | -9,163 | -53,795 | -53,560 | -51,176 | -23,543 | Upgrade
|
| Free Cash Flow Margin | -193.23% | -49.06% | -8810.69% | -3926.36% | - | - | Upgrade
|
| Free Cash Flow Per Share | -1609.86 | -976.77 | -6674.28 | -6508.66 | -7006.11 | -7038.60 | Upgrade
|
| Cash Interest Paid | 140.66 | 454.26 | 510.72 | 247.05 | 121.4 | 160.2 | Upgrade
|
| Cash Income Tax Paid | 39.41 | 1,896 | 83.39 | 354.64 | -4.19 | - | Upgrade
|
| Levered Free Cash Flow | -8,269 | -28,427 | -29,052 | -14,039 | -129,054 | 56,354 | Upgrade
|
| Unlevered Free Cash Flow | -7,871 | -27,535 | -27,203 | -13,407 | -125,484 | 64,962 | Upgrade
|
| Change in Net Working Capital | -339.86 | 25,714 | -1,252 | -22,516 | 91,762 | -77,488 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.